Mellander L - Search Results

1

Immune reconstitution after childhood acute lymphoblastic leukemia is most severely affected in the high risk group.

Ek T, Mellander L, Andersson B, Abrahamsson J. Ek T, et al. Among authors: mellander l. Pediatr Blood Cancer. 2005 May;44(5):461-8. doi: 10.1002/pbc.20255. Pediatr Blood Cancer. 2005. PMID: 15558707

2

Intensive treatment for childhood acute lymphoblastic leukemia reduces immune responses to diphtheria, tetanus, and Haemophilus influenzae type b.

Ek T, Mellander L, Hahn-Zoric M, Abrahamsson J. Ek T, et al. Among authors: mellander l. J Pediatr Hematol Oncol. 2004 Nov;26(11):727-34. doi: 10.1097/00043426-200411000-00008. J Pediatr Hematol Oncol. 2004. PMID: 15543007

3

Avidity of tetanus and Hib antibodies after childhood acute lymphoblastic leukaemia - implications for vaccination strategies.

Ek T, Mellander L, Hahn-Zoric M, Abrahamsson J. Ek T, et al. Among authors: mellander l. Acta Paediatr. 2006 Jun;95(6):701-6. doi: 10.1080/08035250500459717. Acta Paediatr. 2006. PMID: 16754551

4

Interferon gamma and tumour necrosis factor alpha in relation to anaemia and prognosis in childhood cancer.

Ek T, Mellander L, Abrahamsson J. Ek T, et al. Among authors: mellander l. Acta Paediatr. 2005 Apr;94(4):435-7. doi: 10.1111/j.1651-2227.2005.tb01914.x. Acta Paediatr. 2005. PMID: 16092457

5

Bone marrow immunoglobulin-secreting cells are not reduced in children with leukaemia as compared to children with solid tumours.

Abrahamsson J, Mellander L. Abrahamsson J, et al. Among authors: mellander l. Acta Paediatr. 1997 Feb;86(2):165-9. doi: 10.1111/j.1651-2227.1997.tb08859.x. Acta Paediatr. 1997. PMID: 9055886

6

Serum antibody levels and avidities to Escherichia coli O antigens and poliovirus type 1 antigen are increased in children treated for malignant disease.

Abrahamsson J, Carlsson B, Mellander L. Abrahamsson J, et al. Among authors: mellander l. Med Pediatr Oncol. 1999 Jun;32(6):416-20. doi: 10.1002/(sici)1096-911x(199906)32:6<416::aid-mpo4>3.0.co;2-2. Med Pediatr Oncol. 1999. PMID: 10358699

7

Proinflammatory cytokines mediate the systemic inflammatory response associated with high-dose cytarabine treatment in children.

Ek T, Jarfelt M, Mellander L, Abrahamsson J. Ek T, et al. Among authors: mellander l. Med Pediatr Oncol. 2001 Nov;37(5):459-64. doi: 10.1002/mpo.1230. Med Pediatr Oncol. 2001. PMID: 11745875

8

Immunoglobulin levels and lymphocyte response to mitogenic stimulation in children with malignant disease during treatment and follow-up.

Abrahamsson J, Marky I, Mellander L. Abrahamsson J, et al. Among authors: mellander l. Acta Paediatr. 1995 Feb;84(2):177-82. doi: 10.1111/j.1651-2227.1995.tb13605.x. Acta Paediatr. 1995. PMID: 7756804

9

Re-immunisations after childhood leukaemia.

Ek T, Mellander L, Abrahamsson J. Ek T, et al. Among authors: mellander l. Eur J Haematol. 2005 Aug;75(2):175-6; author reply 179-80. doi: 10.1111/j.1600-0609.2005.00489.x. Eur J Haematol. 2005. PMID: 16000138 No abstract available.

10

Tumor necrosis factor-alpha in malignant disease.

Abrahamsson J, Carlsson B, Mellander L. Abrahamsson J, et al. Among authors: mellander l. Am J Pediatr Hematol Oncol. 1993 Nov;15(4):364-9. Am J Pediatr Hematol Oncol. 1993. PMID: 8214357

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

90 results

Search Page